Education
About Us
Working with TipRanks
Follow Us
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
Total Valuation
OncoSil Medical Ltd has a market cap or net worth of AU$32.10M. The enterprise value is AU$9.21M.
Market CapAU$32.10M
Enterprise ValueAU$9.21M
Share Statistics
OncoSil Medical Ltd has 18,827,215 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,827,215
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OncoSil Medical Ltd’s return on equity (ROE) is -4.87 and return on invested capital (ROIC) is -479.96%.
Return on Equity (ROE)-4.87
Return on Assets (ROA)-2.11
Return on Invested Capital (ROIC)-479.96%
Return on Capital Employed (ROCE)-4.96
Revenue Per Employee585.40K
Profits Per Employee0.00
Employee Count2
Asset Turnover0.16
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OncoSil Medical Ltd is ―. OncoSil Medical Ltd’s PEG ratio is -0.00003.
PE Ratio―
PS Ratio11.20
PB Ratio4.23
Price to Fair Value4.23
Price to FCF-1.09
Price to Operating Cash Flow-1.64
PEG Ratio-0.00003
Income Statement
In the last 12 months, OncoSil Medical Ltd had revenue of 1.17M and earned -15.10M in profits. Earnings per share was -1.38.
Revenue1.17M
Gross Profit-1.08M
Operating Income-15.49M
Pretax Income-15.10M
Net Income-15.10M
EBITDA-15.06M
Earnings Per Share (EPS)-1.38
Cash Flow
In the last 12 months, operating cash flow was -12.06M and capital expenditures -14.96K, giving a free cash flow of -12.08M billion.
Operating Cash Flow-12.06M
Free Cash Flow-12.08M
Free Cash Flow per Share-0.64
Dividends & Yields
OncoSil Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change-69.64%
50-Day Moving Average1.37
200-Day Moving Average―
Relative Strength Index (RSI)56.87
Average Volume (3m)24.58K
Important Dates
OncoSil Medical Ltd upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
OncoSil Medical Ltd as a current ratio of 1.67, with Debt / Equity ratio of 2.25%
Current Ratio1.67
Quick Ratio1.67
Debt to Market Cap<0.01
Net Debt to EBITDA0.33
Interest Coverage Ratio-21.45K
Taxes
In the past 12 months, OncoSil Medical Ltd has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
OncoSil Medical Ltd EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.67.
EV to Sales6.90
EV to EBITDA-0.54
EV to Free Cash Flow-0.67
EV to Operating Cash Flow-0.67
Balance Sheet
OncoSil Medical Ltd has AU$5.11M in cash and marketable securities with AU$69.92K in debt, giving a net cash position of AU$5.04M billion.
Cash & Marketable SecuritiesAU$5.11M
Total DebtAU$69.92K
Net CashAU$5.04M
Net Cash Per ShareAU$0.27
Tangible Book Value Per ShareAU$0.28
Margins
Gross margin is -402.21%, with operating margin of -1322.94%, and net profit margin of -1289.71%.
Gross Margin-402.21%
Operating Margin-1322.94%
Pretax Margin-1289.71%
Net Profit Margin-1289.71%
EBITDA Margin-1286.60%
EBIT Margin-1289.65%
Analyst Forecast
The average price target for OncoSil Medical Ltd is AU$1.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$1.50
Price Target Upside-11.76% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast126.62%
EPS Growth Forecast33.53%